Press Release: Competition: Commission fines AstraZeneca EUR60 million for misusing patent system to delay market entry of competing generic drugs

Author (Corporate)
Series Title
Series Details IP/05/737 (15.6.05)
Publication Date 15/06/2005
Content Type

The European Commission on 15 June 2005 fined Anglo-Swedish group AstraZeneca €60 million for misusing the patent system and the procedures for marketing pharmaceuticals to block or delay market entry for generic competitors to its ulcer drug Losec. The Commission decided that AstraZeneca's actions constituted serious abuses of its dominant market position in violation of EC and EEA competition rules.
Source Link http://europa.eu/rapid/pressReleasesAction.do?reference=IP/05/737&format=HTML&aged=0&language=EN&guiLanguage=en
Subject Categories ,
Countries / Regions ,